US Stock MarketDetailed Quotes

IBO Impact BioMedical

Watchlist
  • 2.610
  • -0.010-0.38%
Close Nov 22 16:00 ET
  • 2.610
  • 0.0000.00%
Post 20:01 ET
30.03MMarket Cap25.84P/E (TTM)

About Impact BioMedical Company

Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.

Company Profile

SymbolIBO
Company NameImpact BioMedical
Listing DateSep 16, 2024
Founded2018
CEOMr. Frank D. Heuszel
MarketAMEX
Fiscal Year Ends12-31
Address1400 Broadfield Boulevard,Suite 130
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77084
Phone1-585-325-3610

Company Executives

  • Name
  • Position
  • Salary
  • Frank D. Heuszel
  • Chief Executive Officer, President and Chairman of the Board
  • --
  • Mark Suseck
  • Chief Operating Officer
  • --
  • Todd D. Macko
  • Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
  • --
  • Melissa Sims
  • Director
  • --
  • Dr. Elise Brownell, PhD
  • Director
  • --
  • Jason Grady
  • Director
  • --
  • Castel Hibbert
  • Independent Director
  • --
  • David Keene
  • Independent Director
  • --
  • Christian Zimmerman
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data